{
 "drug": "Peginterferon alfa-2a Injection",
 "asOf": "2026-08-25",
 "status": "in-shortage",
 "since": "01/24/2025",
 "dayN": 578,
 "cat": "Antiviral",
 "companies": [
  "pharmaand GmbH (pharma&)"
 ],
 "reasons": [
  "Regulatory delay"
 ],
 "records": [
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/24/2025",
   "package_ndc": "82154-0451-4",
   "generic_name": "Peginterferon alfa-2a Injection",
   "contact_info": "800-506-8501, email: medinfo.us@pharmaand.com",
   "availability": "Available",
   "openfda": {
    "application_number": [
     "BLA103964"
    ],
    "brand_name": [
     "PEGASYS"
    ],
    "generic_name": [
     "PEGINTERFERON ALFA-2A"
    ],
    "manufacturer_name": [
     "pharmaand GmbH"
    ],
    "product_ndc": [
     "82154-0451",
     "82154-0449"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "PEGINTERFERON ALFA-2A"
    ],
    "rxcui": [
     "351270",
     "352297",
     "731326",
     "731328"
    ],
    "spl_id": [
     "560699fb-9630-ebaa-e063-6394a90ad0ab"
    ],
    "spl_set_id": [
     "d9290e5b-6d40-2318-e053-2995a90a9916"
    ],
    "package_ndc": [
     "82154-0449-1",
     "82154-0451-4"
    ],
    "nui": [
     "N0000175521",
     "M0025711"
    ],
    "pharm_class_epc": [
     "Interferon alpha [EPC]"
    ],
    "pharm_class_cs": [
     "Interferon-alpha [CS]"
    ],
    "unii": [
     "Q46947FE7K"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Antiviral"
   ],
   "dosage_form": "Injection",
   "presentation": "Pegasys, Injection, 180 ug/.5 mL (NDC 82154-0451-4)",
   "company_name": "pharmaand GmbH (pharma&)",
   "status": "Current"
  },
  {
   "update_type": "Reverified",
   "initial_posting_date": "01/24/2025",
   "package_ndc": "82154-0449-1",
   "generic_name": "Peginterferon alfa-2a Injection",
   "contact_info": "800-506-8501, email: medinfo.us@pharmaand.com",
   "availability": "Unavailable",
   "related_info": "Product replenishment timeline to be confirmed sometime in Q1 2027 or earlier.",
   "openfda": {
    "application_number": [
     "BLA103964"
    ],
    "brand_name": [
     "PEGASYS"
    ],
    "generic_name": [
     "PEGINTERFERON ALFA-2A"
    ],
    "manufacturer_name": [
     "pharmaand GmbH"
    ],
    "product_ndc": [
     "82154-0449",
     "82154-0451"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "SUBCUTANEOUS"
    ],
    "substance_name": [
     "PEGINTERFERON ALFA-2A"
    ],
    "rxcui": [
     "351270",
     "352297",
     "731326",
     "731328"
    ],
    "spl_id": [
     "560699fb-9630-ebaa-e063-6394a90ad0ab"
    ],
    "spl_set_id": [
     "d9290e5b-6d40-2318-e053-2995a90a9916"
    ],
    "package_ndc": [
     "82154-0449-1",
     "82154-0451-4"
    ],
    "nui": [
     "N0000175521",
     "M0025711"
    ],
    "pharm_class_epc": [
     "Interferon alpha [EPC]"
    ],
    "pharm_class_cs": [
     "Interferon-alpha [CS]"
    ],
    "unii": [
     "Q46947FE7K"
    ]
   },
   "update_date": "08/17/2026",
   "therapeutic_category": [
    "Antiviral"
   ],
   "dosage_form": "Injection",
   "presentation": "Pegasys, Injection, 180 ug/1 mL (NDC 82154-0449-1)",
   "company_name": "pharmaand GmbH (pharma&)",
   "shortage_reason": "Regulatory delay",
   "status": "Current"
  }
 ]
}